Clinical trialNARecruiting
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
A Prospective, Single-Center, Open-Label Exploratory Study of 68Ga-SorB PET/CT Imaging for the Diagnosis of Sortilin-Positive Solid Tumors
- Outcome
- Ongoing
- Phase
- NA
- Status
- Recruiting
- Study type
- Interventional
- Start
- 13 August 2026
- Expected end
- 31 December 2028
- Enrollment
- 50 participants
- Sites
- 1
- Primary outcomes
- Incidence of adverse events related to 68Ga-SorB PET/CT; Successful completion of 68Ga-SorB PET/CT imaging; Tumor uptake of 68Ga-SorB measured by SUVmax
- Sponsor
- Other
- Results posted
- No
- Last update
- 15 October 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try